MWNA
RDY icon

Marshall Wace North America’s Dr. Reddy's Laboratories RDY Stock Holding History

Marshall Wace North America’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-29,775
Closed -$414K – 1535
2020
Q3 		$414K Buy
+29,775
New +$355K ﹤0.01% 1009
2020
Q1 		– Sell
-601,345
Closed -$4.88M – 1533
2019
Q4 		$4.88M Sell
601,345
-155,135
-21% -$1.23M 0.02% 394
2019
Q3 		$5.73M Buy
756,480
+714,585
+1,706% +$5.32M 0.03% 341
2019
Q2 		$314K Buy
+41,895
New +$329K ﹤0.01% 967
2018
Q3 		– Sell
-2,591,770
Closed -$16.7M – 1289
2018
Q2 		$16.7M Buy
+2,591,770
New +$16.3M 0.09% 238

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Marshall Wace North America's RDY Position: Q4 2020 in Review

Marshall Wace North America sold out of Dr. Reddy's Laboratories (RDY) in Q4 2020, closing a stake of 29,775 shares — an estimated $414K sold.

Marshall Wace North America first reported a position in RDY in Q2 2018 and held it in 5 quarters. The position peaked at $16.7M in Q2 2018. 174 funds tracked by Wall St. Rank hold RDY as of Q4 2020.

  • Marshall Wace North America reported no remaining Dr. Reddy's Laboratories position as of Q4 2020 after selling out during the quarter.
  • Marshall Wace North America sold 29,775 Dr. Reddy's Laboratories shares in Q4 2020, an estimated $414K.
  • Marshall Wace North America first reported a position in Dr. Reddy's Laboratories in Q2 2018 and held it in 5 quarters.
  • Marshall Wace North America's Dr. Reddy's Laboratories position peaked at $16.7M in Q2 2018.
  • 174 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2020.

Based on Marshall Wace North America's 13F filing for Q4 2020, filed 16 Feb 2021.